RNA, 7SL, cytoplasmic 356, pseudogene (RN7SL356P)

RN7SL356P is a pseudogene related to the 7SL RNA component of the signal recognition particle (SRP), designated as RNA, 7SL, cytoplasmic 356, pseudogene[1][3][7]. Pseudogenes like RN7SL356P are typically non-functional genomic DNA sequences similar to functional genes but lack protein-coding capability and are not known to produce a functional transcript[1][3]. The 7SL RNA, of which this is a pseudogene derivative, normally plays an essential role in co-translational targeting of proteins to the endoplasmic reticulum as part of the signal recognition particle (SRP)[5]. However, as a pseudogene, RN7SL356P does not participate in these processes[1][3]. Most 7SL RNA pseudogenes, including RN7SL356P, have resulted from reverse transcription and reintegration events, and while they may be transcribed, there is currently no evidence this specific pseudogene acts as a therapeutic target, disease gene, or biomarker[1][3][6]. Summary of key points: - RN7SL356P is not a drug target, nor a receptor, enzyme, or transporter. - It is a genomic pseudogene, not known to have current clinical or pharmacological relevance[1]. - There is no evidence for interacting drugs, mechanism of action, or safety/biomarker issues linked to this pseudogene. If you need structured information or a candidate gene relevant to therapy, an active form of 7SL RNA or another functional gene may be appropriate, but RN7SL356P is not one.

Other names

RN7SL356PRNA, 7SL, cytoplasmic 356, pseudogene